Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 known ✓ | P11229 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | BLM | P54132 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | USP2 | O75604 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | PPARG | P37231 | 1/20 | 0.54 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.54 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.54 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.46 |
| ▸ | FPR2 | P25090 | 4/20 | 0.45 |
| ▸ | TGM2 | P21980 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 3/20 | 0.41 |
| ▸ | CA1 | P00915 | 3/20 | 0.41 |
| ▸ | CA2 | P00918 | 3/20 | 0.41 |
| ▸ | CA9 | Q16790 | 3/20 | 0.41 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.40 |
| ▸ | AVPR2 | P30518 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL16593584 | 1.00 | MEN1 (0.54) | MEN1BLMKMT2AUSP2POLB | |
| SCHEMBL12216725 | 0.99 | MEN1 (0.55) | MEN1BLMKMT2AUSP2POLB | |
| Isothiocyanate SCHEMBL28202026 | 0.98 | MEN1 (0.52) | MEN1BLMKMT2AUSP2POLB | |
| SCHEMBL29356053 | 0.94 | MEN1 (0.54) | MEN1BLMKMT2AUSP2POLB | |
| SCHEMBL25596330 | 0.87 | MEN1 (0.45) | MEN1BLMKMT2AUSP2POLB | |
| SCHEMBL21263759 | 0.87 | MEN1 (0.56) | MEN1BLMKMT2AUSP2POLB | |
| Hydrochloric Acid SCHEMBL29370904 | 0.86 | MEN1 (0.51) | MEN1BLMKMT2AUSP2POLB | |
| Hydrochloric Acid SCHEMBL29442119 | 0.85 | USP2 (0.59) | MEN1BLMKMT2AUSP2POLB | |
| Hydrochloric Acid SCHEMBL18617 | 0.85 | MEN1 (0.60) | MEN1BLMKMT2AUSP2POLB | |
| Hydrochloric Acid SCHEMBL30207638 | 0.85 | MEN1 (0.60) | MEN1BLMKMT2AUSP2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 609 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12359115-B2 | Method of treating a subsurface formation with a coated proppant | SAUDI ARABIAN OIL COMPANY (SA) | 2025-07-15 | — | — | US | claimed |
| US-12325825-B2 | Composition for a coated proppant | SAUDI ARABIAN OIL COMPANY (SA) | 2025-06-10 | — | — | US | claimed |
| CN-119775996-A | Biotinylated transition metal synchronous radiation nano probe and preparation method and application thereof | 国家纳米科学中心 | 2025-04-08 | — | — | CN | claimed |
| US-20240392181-A1 | COMPOSITION FOR A COATED PROPPANT | SAUDI ARABIAN OIL COMPANY (SA) | 2024-11-28 | — | — | US | claimed |
| US-20240392180-A1 | METHOD OF TREATING A SUBSURFACE FORMATION WITH A COATED PROPPANT | SAUDI ARABIAN OIL COMPANY (SA) | 2024-11-28 | — | — | US | claimed |
| CN-118226046-B | Troponin I detection kit and preparation method thereof | 广州瑞辉生物科技股份有限公司 | 2024-08-23 | — | — | CN | claimed |
| CN-118389642-A | Method for separating single-stranded DNA in oligonucleotide pool and application thereof | 苏州硅基生物科技有限公司 | 2024-07-26 | — | — | CN | claimed |
| US-20240245808-A1 | POLYMER-MODIFIED MAGNETIC NANOMATERIAL, AND PREPARATION METHOD AND USE THEREOF | TONGJI UNIVERSITY (CN) | 2024-07-25 | — | — | US | claimed |
| CN-118226046-A | Troponin I detection kit and preparation method thereof | 广州瑞辉生物科技股份有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-113652471-B | DNA biosensor based on FRET fluorescence ratio, detection method and cell classification method thereof | 中山大学 | 2024-06-04 | — | — | CN | claimed |
| US-11871895-B2 | Raman spectroscopy reporters and methods for molecular imaging of tissue in vivo | THE JOHNS HOPKINS UNIVERSITY (US) | 2024-01-16 | — | — | US | claimed |
| CN-110484234-B | Fluorescent microsphere and preparation and fluorescent coding method thereof | 深圳唯公生物科技有限公司 | 2023-12-05 | — | — | CN | claimed |
| CN-112782404-B | Multiplex biomarker detection kit based on fluorescence immunoassay method | 湖南博奥瑞康生物科技有限公司 | 2023-06-27 | — | — | CN | claimed |
| CN-116333006-A | Solid phase synthesis method of oligonucleotide with fluorescent marker | 苏州欧利生物医药科技有限公司 | 2023-06-27 | — | — | CN | claimed |
| CN-116179655-A | Real-time fluorescent quantitative detection probe | 北京迅识科技有限公司 | 2023-05-30 | — | — | CN | claimed |
| CN-115915778-A | CsPbI containing heterogeneous mixed fluorescent labeling material 3 Perovskite battery and preparation method thereof | 陕西师范大学 | 2023-04-04 | — | — | CN | claimed |
| CN-114177286-A | Injectable self-healing hydrogel encapsulating mesoporous nano microspheres and preparation method and application thereof | 同济大学 | 2022-03-15 | — | — | CN | claimed |
| WO-2022022532-A1 | ANTIBODY CAPABLE OF SPECIFICALLY BINDING TO 25-HYDROXYVITAMIN D, USE THEREOF AND DIAGNOSTIC KIT | 东莞市朋志生物科技有限公司 | 2022-02-03 | — | — | WO | claimed |
| CN-122080220-A | Anti-TPO antibodies or antigen binding fragments thereof | — | 2026-05-26 | — | — | CN | disclosed |
| CN-113956963-A | Tiled chip used for liquid drop type digital PCR system and fluorescence detection system | 西安天隆科技有限公司 | 2022-01-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11871895-B2 | Raman spectroscopy reporters and methods for molecular imaging of tissue in vivo | MKI67, FABP1, FABP3 | CHRM1 4836/4885MEN1 1536/4885BLM 1226/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.